How are drug development and clinical trials changing?
Achieving deep responses in previously treated CLL patients
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
Promising CLL & FL data from ICML 2017: BGB-3111 and obinituzumab
Effective antibody therapy and updates from the POLLUX and CASTER trials at IMW